COST-EFFECTIVENESS OF BIOLOGICAL TREATMENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN TAIWAN

被引：0
|
作者：
Chen, H. F. [1 ]
Lin, H. Y. [2 ]
Lang, H. C. [1 ]
机构：
[1] Natl Yang Ming Univ, Taipei 112, Taiwan
[2] Vet Gen Hosp, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.414
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A673 / A673
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Benucci, Maurizio
    Saviola, Gianantonio
    Baiardi, Paola
    Manfredi, Mariangela
    [J]. RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1465 - 1469
  • [22] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [23] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Maurizio Benucci
    Gianantonio Saviola
    Paola Baiardi
    Mariangela Manfredi
    [J]. Rheumatology International, 2011, 31 : 1465 - 1469
  • [24] COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF INADEQUATELY RESPONDING RHEUMATOID ARTHRITIS PATIENTS
    Hansen, R. N.
    Best, J. H.
    Sullivan, S. D.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A161 - A161
  • [25] COST-EFFECTIVENESS OF TOFACITINIB FOR PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN CHINA
    Tian, L.
    Guo, Q.
    Xiong, X.
    Wang, L.
    Chen, Y.
    Dong, P.
    Ma, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S241 - S241
  • [26] The cost-effectiveness of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA) in Denmark
    Aagren, M.
    Davies, A.
    Winding, B.
    Cifaldi, M.
    Pang, F.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 15 - 15
  • [27] THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA™) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS
    Bansback, N.
    Brennan, A.
    Sengupta, N.
    Pang, F.
    [J]. RHEUMATOLOGY, 2004, 43 : 77 - 77
  • [28] Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis
    Bojke, Laura
    Epstein, David
    Craig, Dawn
    Rodgers, Mark
    Woolacott, Nerys
    Yang, Huiqin
    Sculpher, Mark
    [J]. RHEUMATOLOGY, 2011, 50 : iv39 - iv47
  • [29] Cost-effectiveness modelling of biological treatment sequences in moderate to severe rheumatoid arthritis in France
    Saraux, Alain
    Gossec, Laure
    Goupille, Philippe
    Bregman, Bruno
    Boccard, Eric
    Dupont, Danielle
    Beresniak, Ariel
    [J]. RHEUMATOLOGY, 2010, 49 (04) : 733 - 740
  • [30] THE COST-EFFECTIVENESS OF ALTERNATIVE TREATMENT SEQUENCES IN RHEUMATOID ARTHRITIS
    Trueman, D.
    Bird, A.
    Mumby-Croft, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
12345